Today: 12 April 2026
Polestar stock (PSNY) jumps on BBVA stake filing as Geely-backed funding stays in focus
2 January 2026
2 mins read

Polestar stock (PSNY) jumps on BBVA stake filing as Geely-backed funding stays in focus

NEW YORK, January 1, 2026, 21:16 ET — Market closed

  • Polestar shares last closed up 9.5% at $21.37 on Dec. 31.
  • BBVA disclosed an 8.4% passive stake in a Schedule 13G; Geely-linked holders updated financing terms in a Schedule 13D amendment.
  • Next focus: Polestar’s Q4 retail sales volume update due Jan. 9.

Polestar Automotive Holding UK PLC’s U.S.-listed shares closed sharply higher in the last session of 2025 as investors digested fresh ownership filings that detailed new stakes and financing arrangements around the Swedish electric-vehicle maker.

Why this matters now: Polestar has leaned on its controlling shareholder network for liquidity, and the new documents spell out how banks and Geely-linked entities are structuring exposure — including downside protection and potential equity conversion features.

U.S. equity markets were closed on Thursday for the New Year’s Day holiday, leaving Wednesday’s close as the latest reference point for PSNY.

Polestar ended Dec. 31 up $1.85, or 9.48%, at $21.37, after trading between $19.24 and $21.65, with about 336,600 shares changing hands. The stock was last indicated at $21.24 in extended hours, down about 0.6%.

In a Schedule 13G dated Dec. 31, Banco Bilbao Vizcaya Argentaria S.A. (BBVA) reported beneficial ownership of 7,755,946 Class A American Depositary Shares, representing 8.4% of the class. A Schedule 13G is a filing used to disclose a passive stake of more than 5%.

The filing also said BBVA entered a put option — a contract that gives the holder the right to sell — with Geely Sweden Automotive Investment AB, allowing BBVA to sell the ADSs at the end of a three-year term at a pre-determined price, or earlier if certain events occur.

Separately, a Schedule 13D amendment dated Dec. 30 updated terms around Polestar’s Geely-related financing. Schedule 13D is typically used to disclose large positions that can be associated with influence or control.

That amendment described a $600 million term loan facility with Geely Sweden Automotive Investment AB, including a $300 million committed portion and a second $300 million uncommitted portion that would require lender consent. The lender is a wholly owned subsidiary of Geely Sweden Holdings AB, described in the filing as the parent company of Volvo Car AB.

The document said the facility is available to draw until March 31, 2026, and is repayable six months after any borrowing, unless the lender exercises an option to convert all or part of the loan and accrued interest into shares at a price based on a five-day average of Nasdaq closing prices. The filing also noted that a previously disclosed private investment in public equity (PIPE) transaction closed on Dec. 23.

Polestar’s recent capital-raising has relied on outside financial institutions alongside Geely support. In a Dec. 19 announcement of a $300 million equity investment by BBVA and Natixis and a planned Geely-related debt-to-equity conversion, CEO Michael Lohscheller said the transactions “significantly enhance our liquidity position and help strengthen our balance sheet.” Nasdaq

Investors’ next near-term datapoint is demand. Polestar has said it expects to report its retail sales volumes for the fourth quarter of 2025 on Jan. 9.

Before the next session, traders will also track macro signals that can move rate-sensitive growth stocks. MarketWatch’s calendar showed S&P Global’s final U.S. manufacturing reading for December is due at 9:45 a.m. ET on Friday, Jan. 2.

Beyond Friday, the Institute for Supply Management said its Manufacturing ISM PMI report for December data is scheduled for 10:00 a.m. ET on Monday, Jan. 5, while the U.S. Labor Department’s December employment report is scheduled for 8:30 a.m. ET on Friday, Jan. 9.

On the chart, Wednesday’s session left traders watching the $22 area after the stock peaked near $21.65, with the day’s lows around $19.24 providing the nearest reference for support if momentum fades.

Stock Market Today

  • Clorox Acquires GOJO Industries, Adding Purell to Its Health and Hygiene Portfolio
    April 12, 2026, 3:56 PM EDT. Clorox (NYSE:CLX) has finalized its acquisition of GOJO Industries, the maker of Purell hand sanitizer, expanding its footprint in health and hygiene products beyond traditional cleaning supplies. This move integrates Purell's broad hygiene solutions into Clorox's offerings, potentially creating new opportunities across consumer, professional, and healthcare markets. Investors should focus on how effectively Clorox merges GOJO's operations, especially amid cost inflation and margin pressures. Efficient integration could allow bundled cleaning and hygiene solutions, enhancing market reach. While the acquisition strengthens Clorox's presence alongside competitors like Procter & Gamble and Reckitt, it introduces operational complexity that may affect the company's cost-saving initiatives. Overall, the deal aligns with evolving hygiene standards and consumer habits, offering growth potential but requiring careful execution.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
AXSM stock jumps after FDA sets April 30 decision date for Axsome’s AXS-05 in Alzheimer’s agitation
Previous Story

AXSM stock jumps after FDA sets April 30 decision date for Axsome’s AXS-05 in Alzheimer’s agitation

Arcutis Biotherapeutics stock today: ARQT ends 2025 up 3.4% as traders eye FDA, earnings dates
Next Story

Arcutis Biotherapeutics stock today: ARQT ends 2025 up 3.4% as traders eye FDA, earnings dates

Go toTop